Mechanisms of Alcohol Sensitivity in AERD

Sponsor
University of Virginia (Other)
Overall Status
Unknown status
CT.gov ID
NCT03441438
Collaborator
(none)
60
1
3
4
14.8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine what type of reactions in the body may be responsible for the respiratory symptoms that occur when patients with Aspirin Exacerbated Respiratory Disease (AERD) drink alcoholic beverages. These reactions are most often seen with red wine.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Water
  • Dietary Supplement: Red wine
  • Dietary Supplement: Polyphenolic Compounds
N/A

Detailed Description

This is a prospective trial of approximately 60 subjects with AERD to explore the mechanisms behind the physiologic reactions that occur when drinking alcoholic beverages. At various time points patients will be asked to ingest a variety of substances found in red wine after which blood and urine markers of the reaction will be measured.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Mechanisms of Alcohol Sensitivity in Aspirin Exacerbated Respiratory Disease
Actual Study Start Date :
May 1, 2018
Anticipated Primary Completion Date :
Sep 1, 2018
Anticipated Study Completion Date :
Sep 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control

Patients without asthma or aspirin intolerance who may or may not react to alcoholic beverages

Dietary Supplement: Water
Serum and urine markers will be obtained after drinking 5 oz of water

Dietary Supplement: Red wine
Serum and urine markers will be obtained after drinking 5 oz of water

Dietary Supplement: Polyphenolic Compounds
Serum and urine markers will be obtained after consuming 100 mg of provinols powder

Active Comparator: Aspirin Tolerant Asthma

Patients with asthma who are tolerant to aspirin and/or other NSAIDs and note sensitivity to alcoholic beverages

Dietary Supplement: Water
Serum and urine markers will be obtained after drinking 5 oz of water

Dietary Supplement: Red wine
Serum and urine markers will be obtained after drinking 5 oz of water

Dietary Supplement: Polyphenolic Compounds
Serum and urine markers will be obtained after consuming 100 mg of provinols powder

Active Comparator: Aspirin Intolerant Asthma / AERD

Patients with AERD who note sensitivity to alcoholic beverages

Dietary Supplement: Water
Serum and urine markers will be obtained after drinking 5 oz of water

Dietary Supplement: Red wine
Serum and urine markers will be obtained after drinking 5 oz of water

Dietary Supplement: Polyphenolic Compounds
Serum and urine markers will be obtained after consuming 100 mg of provinols powder

Outcome Measures

Primary Outcome Measures

  1. 24 Hour Urinary Leukotriene-E4 (LTE4) [24 hour]

    Urine LTE4 ng/mg Cr

Secondary Outcome Measures

  1. 24 Hour Urinary Prostaglandin-D2 (PGD2) metabolite [24 hour collection]

    Urine PGD2 metabolite ng/mg Cr

  2. Whole blood Activated Basophil Level [2 hours after ingestion]

    Proportion of activated basophils in whole blood after ingestion

  3. Whole Blood Activated Eosinophil Level [2 hours after ingestion]

    Proportion of activated eosinophils in whole blood after ingestion

  4. Whole Blood tryptase [2 hours after ingestion]

    Level of tryptase concentration in whole blood

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy Controls - must be 21 years or older

  • Aspirin Tolerant Asthma and AERD arms must note a sensitivity to alcoholic beverages

Exclusion Criteria:
  • Enzymopathies

  • Mastocytosis

  • Alcoholism

  • Prior severe respiratory reaction to alcohol consumption

  • Current pregnancy

  • Monoamine Oxidase Inhibitor (MAOI) use

  • Age under 21

  • Use of leukotriene modifier 1 week before study intervention

  • Having undergone and maintained aspirin desensitization

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Virginia Charlottesville Virginia United States 22908

Sponsors and Collaborators

  • University of Virginia

Investigators

  • Principal Investigator: Spencer C Payne, MD, University of Virginia

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Virginia
ClinicalTrials.gov Identifier:
NCT03441438
Other Study ID Numbers:
  • 20382
First Posted:
Feb 22, 2018
Last Update Posted:
May 7, 2018
Last Verified:
May 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Virginia
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 7, 2018